J CLIN PSYCHOPHARM
Publications
- 2019
Potential Explanations for Increasing Methylphenidate Use in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder in Germany From 2004 to 2013
Langner, I., Haug, U., Scholle, O., Lindemann, C., Schröder, C. & Riedel, O., 2019, In: Journal of clinical psychopharmacology. 39, 1, p. 39-45 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2018
Myocarditis During Treatment With Clozapine in 2 Adolescent Cases
Mudra, S., Luedecke, D., Grafmann, M. & Schulte-Markwort, M., 10.2018, In: J CLIN PSYCHOPHARM. 38, 6, p. 639-640 2 p.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
- 2015
Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial
Falcato, L., Beck, T., Reimer, J. & Verthein, U., 01.04.2015, In: J CLIN PSYCHOPHARM. 35, 2, p. 150-7 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2013
No effects of antidepressants on negative symptoms in schizophrenia
Hinkelmann, K., Yassouridis, A., Kellner, M., Jahn, H., Wiedemann, K. & Raedler, T. J., 01.10.2013, In: J CLIN PSYCHOPHARM. 33, 5, p. 686-90 5 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2011
Differential 3-year effects of first- versus second-generation antipsychotics on subjective well-being in schizophrenia using marginal structural models.
Lambert, M., Schimmelmann, B. G., Schacht, A., Suarez, D., Haro, J. M., Novick, D., Wagner, T., Wehmeier, P. M., Huber, C., Hundemer, H-P., Dittmann, R. W. & Naber, D., 2011, In: J CLIN PSYCHOPHARM. 31, 2, p. 226-230 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2010
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study.
Schennach-Wolff, R., Obermeier, M., Seemüller, F., Jäger, M., Schmauss, M., Laux, G., Pfeiffer, H., Naber, D., Schmidt, L. G., Gaebel, W., Klosterkötter, J., Heuser, I., Maier, W., Lemke, M. R., Rüther, E., Klingberg, S., Gastpar, M., Engel, R. R., Möller, H-J. & Riedel, M., 2010, In: J CLIN PSYCHOPHARM. 30, 6, p. 726-731 6.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Low serotonergic function and its normalization by treatment with sertraline in obsessive-compulsive disorder--an auditory evoked potential study.
Mavorgiorgou, P., Gohle, D., Winter, C., Rujescu, D., Pogarell, O., Mulert, C., Bär, K-J., Zaudig, M., Hegerl, U. & Juckel, G., 2010, In: J CLIN PSYCHOPHARM. 30, 3, p. 341-343 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Oral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report.
Hasan, A., Rothenberger, A., Münchau, A., Wobrock, T., Falkai, P. & Roessner, V., 2010, In: J CLIN PSYCHOPHARM. 30, 2, p. 190-192 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis.
Lambert, M., Conus, P., Cotton, S., Robinson, J., McGorry, P. D. & Schimmelmann, B. G., 2010, In: J CLIN PSYCHOPHARM. 30, 5, p. 565-572 5.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Primary add-on of ziprasidone in sertraline treatment of posttraumatic stress disorder: lessons from a stopped trial?
Kellner, M., Muhtz, C. & Wiedemann, K., 2010, In: J CLIN PSYCHOPHARM. 30, 4, p. 471-473 4.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2006
Is quality of life among minimally symptomatic patients with schizophrenia better following withdrawal or continuation of antipsychotic treatment?
Beasley, C. M., Sutton, V. K., Taylor, C. C., Sethuraman, G., Dossenbach, M. & Naber, D., 2006, In: J CLIN PSYCHOPHARM. 26, 1, p. 40-44 1.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Remission and Relapse in the Outpatient Care of Schizophrenia: Three-year Results From the Schizophrenia Outpatient Health Outcome Study.
Haro, J. M., Novick, D., Suarez, D., Alonso, J., Lepine, J. P., Ratcliffe, M., SOHO Study Group & Lambert, M., 2006, In: J CLIN PSYCHOPHARM. 26, p. 571-578Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2005
The influence of olanzapine versus risperidone on facial expression of emotions in schizophrenia--preliminary results of a facial electromyogram study.
Wolf, K., Mass, R., Kiefer, F., Eckert, K., Stritzky, A. V., Haasen, C., Wiedemann, K. & Naber, D., 2005, In: J CLIN PSYCHOPHARM. 25, 3, p. 278-281 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2004
Risperidone in the treatment of acute schizophrenia.
Raedler, T. J., Schreiner, A., Naber, D. & Wiedemann, K., 2004, In: J CLIN PSYCHOPHARM. 24, 3, p. 335-338 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Valproate monotherapy in the treatment of civilian patients with non-combat-related posttraumatic stress disorder: an open-label study.
Otte, C., Wiedemann, K., Yassouridis, A. & Kellner, M., 2004, In: J CLIN PSYCHOPHARM. 24, 1, p. 106-108 1.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review